300 related articles for article (PubMed ID: 33990626)
21. Physiological stress improves stem cell modeling of dystrophic cardiomyopathy.
Fullenkamp DE; Willis AB; Curtin JL; Amaral AP; Dittloff KT; Harris SI; Chychula IA; Holgren CW; Burridge PW; Russell B; Demonbreun AR; McNally EM
Dis Model Mech; 2024 Jun; 17(6):. PubMed ID: 38050701
[TBL] [Abstract][Full Text] [Related]
22. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
[TBL] [Abstract][Full Text] [Related]
23. The intracellular Ca2+ concentration is elevated in cardiomyocytes differentiated from hiPSCs derived from a Duchenne muscular dystrophy patient.
Tsurumi F; Baba S; Yoshinaga D; Umeda K; Hirata T; Takita J; Heike T
PLoS One; 2019; 14(3):e0213768. PubMed ID: 30875388
[TBL] [Abstract][Full Text] [Related]
24. Increased tissue stiffness triggers contractile dysfunction and telomere shortening in dystrophic cardiomyocytes.
Chang ACY; Pardon G; Chang ACH; Wu H; Ong SG; Eguchi A; Ancel S; Holbrook C; Ramunas J; Ribeiro AJS; LaGory EL; Wang H; Koleckar K; Giaccia A; Mack DL; Childers MK; Denning C; Day JW; Wu JC; Pruitt BL; Blau HM
Stem Cell Reports; 2021 Sep; 16(9):2169-2181. PubMed ID: 34019816
[TBL] [Abstract][Full Text] [Related]
25. Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: The impact of full-length dystrophin deficiency.
Pioner JM; Santini L; Palandri C; Langione M; Grandinetti B; Querceto S; Martella D; Mazzantini C; Scellini B; Giammarino L; Lupi F; Mazzarotto F; Gowran A; Rovina D; Santoro R; Pompilio G; Tesi C; Parmeggiani C; Regnier M; Cerbai E; Mack DL; Poggesi C; Ferrantini C; Coppini R
Front Physiol; 2022; 13():1030920. PubMed ID: 36419836
[TBL] [Abstract][Full Text] [Related]
26. Establishment of a Duchenne muscular dystrophy patient-derived induced pluripotent stem cell line carrying a deletion of exons 51-53 of the dystrophin gene (CCMi003-A).
Rovina D; Castiglioni E; Farini A; Bellichi M; Gervasini C; Paganini S; Di Segni M; Santoro R; Torrente Y; Pompilio G; Gowran A
Stem Cell Res; 2019 Oct; 40():101544. PubMed ID: 31465894
[TBL] [Abstract][Full Text] [Related]
27. Functional correction of dystrophin actin binding domain mutations by genome editing.
Kyrychenko V; Kyrychenko S; Tiburcy M; Shelton JM; Long C; Schneider JW; Zimmermann WH; Bassel-Duby R; Olson EN
JCI Insight; 2017 Sep; 2(18):. PubMed ID: 28931764
[TBL] [Abstract][Full Text] [Related]
28. Generation of Induced Pluripotent Stem Cells From Patients With Duchenne Muscular Dystrophy and Their Induction to Cardiomyocytes.
Hashimoto A; Naito AT; Lee JK; Kitazume-Taneike R; Ito M; Yamaguchi T; Nakata R; Sumida T; Okada K; Nakagawa A; Higo T; Kuramoto Y; Sakai T; Tominaga K; Okinaga T; Kogaki S; Ozono K; Miyagawa S; Sawa Y; Sakata Y; Morita H; Umezawa A; Komuro I
Int Heart J; 2016; 57(1):112-7. PubMed ID: 26673445
[TBL] [Abstract][Full Text] [Related]
29. Generation and characterization of an induced pluripotent stem cell line (ZSYYDNi001-A) from a patient with Duchenne muscular dystrophy carrying exon 51 deletion in the DMD gene.
Wang L; Li H; Li Y; Xu M; Lin J; Liao Z; Pei Z; Zhang C
Stem Cell Res; 2021 Oct; 56():102553. PubMed ID: 34619646
[TBL] [Abstract][Full Text] [Related]
30. Generation of microRNA-378a-deficient hiPSC as a novel tool to study its role in human cardiomyocytes.
Martyniak A; Andrysiak K; Motais B; Coste S; Podkalicka P; Ferdek P; Stępniewski J; Dulak J
J Mol Cell Cardiol; 2021 Nov; 160():128-141. PubMed ID: 34329686
[TBL] [Abstract][Full Text] [Related]
31. Patient-Specific and Gene-Corrected Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Short QT Syndrome.
Guo F; Sun Y; Wang X; Wang H; Wang J; Gong T; Chen X; Zhang P; Su L; Fu G; Su J; Yang S; Lai R; Jiang C; Liang P
Circ Res; 2019 Jan; 124(1):66-78. PubMed ID: 30582453
[TBL] [Abstract][Full Text] [Related]
32. Investigation of a dilated cardiomyopathy-associated variant in BAG3 using genome-edited iPSC-derived cardiomyocytes.
McDermott-Roe C; Lv W; Maximova T; Wada S; Bukowy J; Marquez M; Lai S; Shehu A; Benjamin I; Geurts A; Musunuru K
JCI Insight; 2019 Nov; 4(22):. PubMed ID: 31723063
[TBL] [Abstract][Full Text] [Related]
33. Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.
Chun JL; O'Brien R; Song MH; Wondrasch BF; Berry SE
Stem Cells Transl Med; 2013 Jan; 2(1):68-80. PubMed ID: 23283493
[TBL] [Abstract][Full Text] [Related]
34. Generation of three Duchenne muscular dystrophy patient-derived induced pluripotent stem cell (iPSC) lines ICGi002-A, ICGi002-B and ICGi002-C.
Valetdinova KR; Maretina MA; Vyatkin YV; Perepelkina MP; Egorova AA; Baranov VS; Kiselev AV; Gershovich PM; Zakian SM
Stem Cell Res; 2020 Oct; 48():101941. PubMed ID: 32777771
[TBL] [Abstract][Full Text] [Related]
35. CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors.
Jin Y; Shen Y; Su X; Weintraub N; Tang Y
J Vis Exp; 2019 Sep; (151):. PubMed ID: 31566614
[TBL] [Abstract][Full Text] [Related]
36. YAP Induces Human Naive Pluripotency.
Qin H; Hejna M; Liu Y; Percharde M; Wossidlo M; Blouin L; Durruthy-Durruthy J; Wong P; Qi Z; Yu J; Qi LS; Sebastiano V; Song JS; Ramalho-Santos M
Cell Rep; 2016 Mar; 14(10):2301-12. PubMed ID: 26947063
[TBL] [Abstract][Full Text] [Related]
37. Can Human Pluripotent Stem Cell-Derived Cardiomyocytes Advance Understanding of Muscular Dystrophies?
Kalra S; Montanaro F; Denning C
J Neuromuscul Dis; 2016 Aug; 3(3):309-332. PubMed ID: 27854224
[TBL] [Abstract][Full Text] [Related]
38. IPSC derived cardiac fibroblasts of DMD patients show compromised actin microfilaments, metabolic shift and pro-fibrotic phenotype.
Soussi S; Savchenko L; Rovina D; Iacovoni JS; Gottinger A; Vialettes M; Pioner JM; Farini A; Mallia S; Rabino M; Pompilio G; Parini A; Lairez O; Gowran A; Pizzinat N
Biol Direct; 2023 Jul; 18(1):41. PubMed ID: 37501163
[TBL] [Abstract][Full Text] [Related]
39. Generation of a pluripotent stem cell line (UMGi270-A) and a corresponding CRISPR/Cas9 modified isogenic control (UMGi270-A-1) from a patient with sudden onset dilated cardiomyopathy harboring a FLNC p.R2187P mutation.
Maurer W; Rebs S; Köhne S; Eberl H; Wollnik B; Zibat A; Streckfuss-Bömeke K
Stem Cell Res; 2024 Jun; 77():103409. PubMed ID: 38583294
[TBL] [Abstract][Full Text] [Related]
40. Pathogenic mechanism and gene correction for LQTS-causing double mutations in KCNQ1 using a pluripotent stem cell model.
Wang Z; Wang L; Liu W; Hu D; Gao Y; Ge Q; Liu X; Li L; Wang Y; Wang S; Li C
Stem Cell Res; 2019 Jul; 38():101483. PubMed ID: 31226583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]